Sequent Scientific's Stock Reaches 52-Week High, Outperforms Sector and Sensex

Sep 24 2024 03:05 PM IST
share
Share Via
Sequent Scientific, a smallcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high on September 24th, 2024. The stock has outperformed the sector by 6.37% and has been on a consecutive gain streak for the past 3 days. Despite high volatility, the stock is trading above its moving averages and has shown a 1-year performance of 119.14%, highlighting its strong potential in the pharmaceutical industry.
Sequent Scientific's Stock Reaches 52-Week High, Outperforms Sector and Sensex
Sequent Scientific, a smallcap pharmaceutical company, has recently seen a surge in its stock price, reaching a 52-week high on September 24th, 2024. The stock has been performing well in the market, with a 'Hold' recommendation from MarketsMOJO. The stock has shown strong performance today, outperforming the sector by 6.37%. It has also been on a consecutive gain streak for the past 3 days, with a 10.98% increase in returns during this period. The stock's intraday high of Rs 193 marks a 7.43% increase. However, it is important to note that the stock has also shown high volatility today, with an intraday volatility of 6.81%. This is calculated from the weighted average price, indicating that the stock's price has fluctuated significantly throughout the day. Despite this, Sequent Scientific is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This suggests that the stock is in an upward trend and has been consistently performing well in the market. In comparison to the Sensex, Sequent Scientific has shown an impressive 1-year performance of 119.14%, while the Sensex has only seen a 28.62% increase. This further highlights the company's strong performance and potential for growth in the pharmaceutical industry. Overall, Sequent Scientific's recent surge in stock price and consistent performance in the market make it a company to watch out for in the smallcap pharmaceutical sector.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News